Geneos Wealth Management’s iShares US Healthcare Providers ETF IHF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-98
Closed -$5.6K 2926
2024
Q3
$5.6K Hold
98
﹤0.01% 2041
2024
Q2
$5.14K Sell
98
-87
-47% -$4.55K ﹤0.01% 1721
2024
Q1
$10.1K Hold
185
﹤0.01% 1545
2023
Q4
$9.71K Hold
185
﹤0.01% 1556
2023
Q3
$9.11K Sell
185
-50
-21% -$2.54K ﹤0.01% 1598
2023
Q2
$12K Hold
235
﹤0.01% 1527
2023
Q1
$11.6K Hold
235
﹤0.01% 1508
2022
Q4
$12.6K Buy
+235
New +$12.6K ﹤0.01% 1468
2021
Q3
Sell
-595
Closed -$32K 2865
2021
Q2
$32K Buy
+595
New +$31.4K ﹤0.01% 1683
2020
Q2
Sell
-250
Closed -$8K 2587
2020
Q1
$8K Hold
250
﹤0.01% 1890
2019
Q4
$10K Hold
250
﹤0.01% 1971
2019
Q3
$8K Hold
250
﹤0.01% 1967
2019
Q2
$8K Hold
250
﹤0.01% 1976
2019
Q1
$8K Hold
250
﹤0.01% 1905
2018
Q4
$8K Buy
+250
New +$9.48K ﹤0.01% 1849
2016
Q2
Sell
-125
Closed -$3K 1823
2016
Q1
$3K Buy
+125
New +$2.91K ﹤0.01% 1606

Other funds holding IHF

Geneos Wealth Management's IHF Position: Q4 2024 in Review

Geneos Wealth Management sold out of iShares US Healthcare Providers ETF (IHF) in Q4 2024, closing a stake of 98 shares — an estimated $5.6K sold.

Geneos Wealth Management first reported a position in IHF in Q1 2016 and held it in 16 quarters. The position peaked at $32K in Q2 2021. 198 funds tracked by Wall St. Rank hold IHF as of Q4 2024.

  • Geneos Wealth Management reported no remaining iShares US Healthcare Providers ETF position as of Q4 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 98 iShares US Healthcare Providers ETF shares in Q4 2024, an estimated $5.6K.
  • Geneos Wealth Management first reported a position in iShares US Healthcare Providers ETF in Q1 2016 and held it in 16 quarters.
  • Geneos Wealth Management's iShares US Healthcare Providers ETF position peaked at $32K in Q2 2021.
  • 198 funds tracked by Wall St. Rank held iShares US Healthcare Providers ETF as of Q4 2024.

Based on Geneos Wealth Management's 13F filing for Q4 2024, filed 21 Jan 2025.